![N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺](https://stcdn.activebiopharma.com/active/ABP000955.png)
化学名称 : N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺
CAS : 864082-47-3
英文名称: GSK429286A
英文同义词: N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide
溶解度:Unknown
储存条件:at -20℃ 2 years
生物活性
LY2603618 (IC-83) is a highly selective Chk 1 inhibitor with potential antitumor activity. LY2603618 (IC-83) binds to and inhibits the activity of chk1, which may prevent the repair of DNA caused by DNA-damaging agents, thus potentiating the antitumor efficacies of various chemotherapeutic agents. Chk1, an ATP-dependent serine-threonine kinase, is a key component in the DNA replication-monitoring checkpoint system and is activated by double-stranded breaks (DSBs); activated chk1 is overexpressed by a variety of cancer cell types. [1][2]
参考文献
异吲哚啉
496-12-8
匹格列酮
111025-46-8
2-氨基-4-[2,4-二氯-5-[2-(1-吡咯烷基)乙氧基]苯基]-N-乙基噻吩并[2,3-D]嘧啶-6-甲酰胺
847559-80-2
腺苷
5536-17-4